Clinical trials
Phase 2 Triple Negative Breast Neoplasms trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 1 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Terminated | 5 |
| Active, not recruiting | 4 |
| Recruiting | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Queen Mary University of London | 3 |
| Institute of Cancer Research, United Kingdom | 2 |
| Merck Sharp & Dohme LLC | 2 |
| AstraZeneca | 1 |
| Ayala Pharmaceuticals, Inc, | 1 |
| BerGenBio ASA | 1 |
| BioNTech SE | 1 |
| Celldex Therapeutics | 1 |
| Gilead Sciences | 1 |
| MedSIR | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 19 |
| Breast Neoplasms | 8 |
| Stomach Neoplasms | 3 |
| Biliary Tract Neoplasms | 1 |
| Carcinoma, Lobular | 1 |
| Colorectal Neoplasms | 1 |
| Glioblastoma | 1 |
| Inflammatory Breast Neoplasms | 1 |
| Neoplasm Metastasis | 1 |
| Ovarian Neoplasms | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.